TEVA · Categories · Upgrades
TEVA - Analyst upgrades
Teva Pharmaceutical Industries Limited (TEVA) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for TEVA
- Teva Pharma upgraded by Analyst with a new price targetAnalyst upgraded Teva Pharma from Neutral to Overweight and set a new price target of $23.00
- Teva Pharma upgraded by Argus with a new price targetArgus upgraded Teva Pharma from Hold to Buy and set a new price target of $20.00
- Teva Pharma upgraded by JP Morgan with a new price targetJP Morgan upgraded Teva Pharma from Underweight to Neutral and set a new price target of $14.00
- Teva Pharma upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Teva Pharma from Neutral to Overweight and set a new price target of $19.00 from $12.00 previously
- Teva Pharma upgraded by Jefferies with a new price targetJefferies upgraded Teva Pharma from Hold to Buy and set a new price target of $14.00 from $10.00 previously
- Teva Pharma upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Teva Pharma from Underweight to Neutral and set a new price target of $12.00 from $8.00 previously
- Teva Pharma upgraded by UBS with a new price targetUBS upgraded Teva Pharma from Neutral to Buy and set a new price target of $13.00 from $11.00 previously
- Teva Pharma upgraded by UBS with a new price targetUBS upgraded Teva Pharma from Sell to Neutral and set a new price target of $8.00 from $7.00 previously
- Teva Pharma upgraded by Evercore ISIEvercore ISI upgraded Teva Pharma from In-line to Outperform
- Teva Pharma upgraded by BofA Securities with a new price targetBofA Securities upgraded Teva Pharma from Neutral to Buy and set a new price target of $13.00 from $10.00 previously
- Teva Pharma upgraded by BofA Securities with a new price targetBofA Securities upgraded Teva Pharma from Underperform to Neutral and set a new price target of $9.00
- Teva Pharma upgraded by Barclays with a new price targetBarclays upgraded Teva Pharma from Equal Weight to Overweight and set a new price target of $13.00 from $11.00 previously
- Teva Pharma upgraded by Bernstein with a new price targetBernstein upgraded Teva Pharma from Mkt Perform to Outperform and set a new price target of $11.00